Eli Lilly and Company

Data reveals Lilly's PKC ß inhibitor improved symptomatic diabetic peripheral neuropathy

LY333531 improves nerve function and sensory symptoms, including tingling and numbness, of diabetic neuropathy. The treatment is being studied for multiple diabetic microvascular complications, including diabetic retinopathy and nephropathy.

SourceEli Lilly and Company·DateJun 18, 2002

Researchers At Eli Lilly And Company Provide A New Understanding Of How Estrogen May Impact Women

Researchers at Eli Lilly have discovered a new pathway through which estrogen affects various organs, including the bones and cardiovascular system. The study provides a potential explanation for how estrogen regulates body functions in different tissues.

SourceEli Lilly and Company·DateAug 29, 1996